BRUISE CONTROL-2: Continued vs. Interrupted use of Direct Oral Anticoagulants in Pacemaker or Defibrillator Surgery
Research attempts to answer the question of how to manage anticoagulants in patients at the time of device surgery.
Dr. David Birnie and his colleagues conducted a 662-patient, multicentre, single-blind, randomized controlled trial at 15 centres in Canada and one in Israel between 2013 and 2017.
“The bottom line is there was no difference between the two strategies. In both arms the event rate of device hematomas was extremely low and that is good news for patients.”
– Dr. David Birnie
